Immunotherapy advancements

Non-Small Cell Lung Cancer: New Treatment Innovations

Marga / January 10, 2025

Did you know that non-small cell lung cancer, or NSCLC, makes up around 85% of all lung cancer cases? Every […]

Marga / January 1, 2025

Machine learning algorithms now diagnose lung cancer types with 97% accuracy. This shows the power of technology in health care,

Marga / December 23, 2024

Did you know that more than 200,000 new cases of non-small-cell lung cancer are diagnosed yearly in the United States?

Marga / December 21, 2024

Did you know that durvalumab can significantly help patients with stage III lung cancer? Recent studies show these patients have

Marga / December 7, 2024

Lung cancer is the second-most common cancer and the top cause of cancer death in the U.S. It claims over

Marga / December 6, 2024

In a recent study of more than 197,000 patients with stage IV non-small cell lung cancer (NSCLC), about 7.3% started

Marga / December 6, 2024

Lung cancer is the top reason for cancer deaths in the US, taking over 27,000 lives daily. This fact highlights

Marga / December 1, 2024

Did you know in the ADRIATIC trial, over 57% of people taking durvalumab were still alive after three years? This